What does Harvard Apparatus Regenerative Technology, Inc. do?

Harvard Apparatus Regenerative Technology, Inc. is a public company in the Surgical & Medical Instruments & Apparatus industry, incorporated in DE. It is registered with the SEC under CIK 0001563665 and trades on OTC under the ticker HRGN.

What is Harvard Apparatus Regenerative Technology, Inc.'s annual revenue?

Harvard Apparatus Regenerative Technology, Inc. reported $0 in revenue for fiscal year 2021, according to its 10-K filing with the SEC.

Is Harvard Apparatus Regenerative Technology, Inc. profitable?

Harvard Apparatus Regenerative Technology, Inc. reported a net loss of $6.87M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Harvard Apparatus Regenerative Technology, Inc. made?

Harvard Apparatus Regenerative Technology, Inc. has filed 613 documents with the SEC since 2012. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Harvard Apparatus Regenerative Technology, Inc.

HRGN OTC CIK: 0001563665 Surgical & Medical Instruments & Apparatus Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 613 filings →

Form	Description	Date
10-K	FORM 10-K	Mar 19, 2026
D	—	Jan 6, 2026
8-K	FORM 8-K	Jan 6, 2026
4	FORM 4	Dec 1, 2025
10-Q	FORM 10-Q	Nov 7, 2025
4	FORM 4	Oct 1, 2025
4	FORM 4	Sep 24, 2025
4	FORM 4	Sep 2, 2025
10-Q	FORM 10-Q	Aug 11, 2025
D	—	Jul 14, 2025

Insider Transactions

View all →

Insider	Title	Type	Shares	Owns After	Date
He Junli	CEO	Purchase	3,000 @ $1.70	280,575	Nov 25, 2025
He Junli	CEO	Purchase	300 @ $1.98	277,575	Sep 30, 2025
He Junli	CEO	Purchase	11,225 @ $1.85	277,275	Sep 2, 2025
He Junli	CEO	Purchase	4,050 @ $1.72	266,050	Aug 21, 2025
He Junli	CEO	Purchase	2,299 @ $2.87	262,000	Dec 24, 2024
He Junli	CEO	Purchase	5,101 @ $3.37	259,701	Aug 27, 2024
He Junli	CEO	Purchase	1,600 @ $2.80	254,600	Jun 21, 2024
He Junli	CEO	Purchase	2,700 @ $4.76	253,000	Dec 27, 2023
He Junli	CEO	Purchase	900 @ $4.92	250,300	Dec 14, 2023
He Junli	CEO	Purchase	1,500 @ $5.07	249,400	Dec 6, 2023

Insider Sentiment (12 months)

Net buying vs selling by insiders based on Form 4 filings.

Net Buying

Buys (4): $33,426
Sells (0): $0

All insider transactions →

About This Profile

This page aggregates all publicly available SEC EDGAR data for Harvard Apparatus Regenerative Technology, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $0 (FY2021)
Net Income: ($6.87M) (FY2025)
Total Assets: $2.68M (FY2025)
Operating Income: ($6.92M)

Full financials →

Details

CIK: 0001563665
Ticker: HRGN
Exchange: OTC
Incorporated: DE
First Filing: 2012
Total Filings: 613

Surgical & Medical Instruments & Apparatus rankings →